---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-007455"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2024-06-06T23:59:59+00:00"
generated_at: "2026-06-01T05:48:07.573918+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Zivo Bioscience adopts new Director Equity Plan, boosts share reserves, grants equity to directors and officers

## Summary
- Adopted 2024 Director Equity Plan (875k shares, auto-increase 5%/yr). Director cash fee raised from $40k to $50k, eligible for restricted stock/RSUs.
- Amended 2021 Plan reserve from 166,666 to 1,000,000 shares; terminated 2019 Plan.
- Granted 127,364 restricted shares to directors replacing cancelled options; additional 261,619 shares for unpaid 2023 fees.
- Issued 1,031,425 stock options to officers: CEO John Payne (217,431), CFO Keith Marchiando (444,498) replacing prior options and cash bonus.
- Total unregistered securities issued: 426,671 common shares and options for 1,031,425 shares; outstanding shares at 3,278,807.

## SEC filing metadata
- accession: 0001654954-24-007455
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2024-06-06T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 5.02, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495424007455/0001654954-24-007455-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495424007455/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-007455
- JSON: https://secwatch.observer/filing/0001654954-24-007455.json
- Plain text: https://secwatch.observer/filing/0001654954-24-007455.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.